Contact number
(020) 7583 4055Provided by Chambers
Cooley advised biotech company Mestag Theraputics in a USD1.9 billion cross-border licensing and collaboration agreement with MSD, to identify novel targets for the development of therapies against inflammatory diseases.
Provided by Chambers
Cooley is known for their expertise in the biotech space. They have seen so many deals and are able to bring that expertise to bear. They are effective in creating solutions.
Cooley are extremely well organised and experienced. They can quickly get insights from other departments when needed. The depth and breadth of the team is very strong.
They Cooley team have been invaluable. They have significant expertise across all legal areas, are always responsive and provide pragmatic support.
The service Cooley provides is always first class, demonstrating a young, fresh and client-focused mindset in Big Law.
Cooley offer quick reaction and response times, and provide pragmatic responses to challenging scenarios including complex IP strategies.
Cooley is known for their expertise in the biotech space. They have seen so many deals and are able to bring that expertise to bear. They are effective in creating solutions.
Cooley are extremely well organised and experienced. They can quickly get insights from other departments when needed. The depth and breadth of the team is very strong.
They Cooley team have been invaluable. They have significant expertise across all legal areas, are always responsive and provide pragmatic support.
The service Cooley provides is always first class, demonstrating a young, fresh and client-focused mindset in Big Law.
Cooley offer quick reaction and response times, and provide pragmatic responses to challenging scenarios including complex IP strategies.
Provided by Chambers
Simon Amies is recommended for his stewardship of high-value, cross-border mergers, acquisitions and financings. His clients include leading innovators in pharma, biotech and health tech.
Simon is very calm, commercial and savvy.
Simon continually displays a deep understanding of our legal needs and business constraints. He is personable, reliable and knowledgeable.
Frances Stocks Allen advises biotech, medical devices and pharmaceuticals manufacturers, and sector-focused investors, on major IP-driven transactions. She also has significant experience in cross-border data transfers.
Frances is a strong, solution-oriented lawyer. She is a passionate advocate for her clients and the life sciences ecosystem.
Frances is very knowledgeable and experienced in the biotech space. She provides excellent guidance.
Frances integrates seamlessly into our team and is rigorous in her approach. She draws on the collective knowledge base of her network of colleagues to help us reach the optimal position.
Thomas Goodman has an impressive transactional practice in the sector spanning licence agreements, investment and financing deals. He regularly advises clients in biotech and pharma, as well as major investors.
Thomas is a trusted industry partner to us.
Joe Sandys has a promising practice in cross-border life sciences transactions, including collaborations and licensing deals. He is sought after by clients in biotech and pharma seeking assistance with complex IP-based transactions.
Joe blends real depth of experience with a powerful thoughtfulness in negotiations. He has been great at finding creative solutions.
Joe is really easy to work with and knows his stuff. I have lots of respect for him.